During melanoma progression, the expression of GALNT7 is decreased by miR-30b/30d, which promotes cell invasion and immunosuppression by altering the O-glycosylation patterns of membrane proteins interacting with the ECM and cells of the tumor environment [20]. The gene discussed is GALNT7; the disease is neoplasm.